IL275941A - Physical means and methods for affecting cannabis plants - Google Patents

Physical means and methods for affecting cannabis plants

Info

Publication number
IL275941A
IL275941A IL275941A IL27594120A IL275941A IL 275941 A IL275941 A IL 275941A IL 275941 A IL275941 A IL 275941A IL 27594120 A IL27594120 A IL 27594120A IL 275941 A IL275941 A IL 275941A
Authority
IL
Israel
Prior art keywords
thc
weight ratio
pmf
cannabis
plant
Prior art date
Application number
IL275941A
Other languages
Hebrew (he)
Other versions
IL275941B (en
Inventor
Tamar Dr Levin
Orit Ish-Yemini
Original Assignee
Enp T O Ltd
Tamar Dr Levin
Ish Yemini Orit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enp T O Ltd, Tamar Dr Levin, Ish Yemini Orit filed Critical Enp T O Ltd
Publication of IL275941A publication Critical patent/IL275941A/en
Publication of IL275941B publication Critical patent/IL275941B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/02Processes for modifying phenotypes, e.g. symbiosis with bacteria by controlling duration, wavelength, intensity, or periodicity of illumination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G7/00Botany in general
    • A01G7/04Electric or magnetic or acoustic treatment of plants for promoting growth
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/28Cannabaceae, e.g. cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/14Plasma, i.e. ionised gases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Forests & Forestry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Claims (9)

CLAIMS:
1. A method for increasing at least one parameter of at least one cannabis-derived compound to a range being at least 5% over normal in a non-treated plant; terized by step of emitting a PMF on a cannab is plant or a portion thereof; said parameter is selected from a group consisting chemical parameters; wherein said cannabis-derived compound is selected from a group consisting of one or more cannabinoids, terpenes, and any combination thereof; and further wherein said one or more cannabinoids are selected from a group consisting of Tetra-hydro-cannabinoids (d9- THC), Tetra-hydro-cannabinoids (d8- THC), Tetra-hydro-cannabinolic acid (THCA- d9), Tetra-hydro-cannabivarin (THCV/THC-C3), Cannabidiol (CBD), Cannabidiolic acid (CBDA), Cannabidivarin (CBDV), Cannabigerol (CBG), Cannabigerolic acid (CBGA), inol (CBN), Cannabidiolic acid (CBNA), Cannabichromene (CBC), Cannabichromenic acid (CBCA), and any ation thereof.
2. A method for sing at least one parameter of at least one cannabis-derived nd to a range being at least 5% over normal in a non-treated plant; characterized by step of emitting a PMF on a cannab is plant or a portion thereof; said parameter is selected from a group consisting chemical parameters; n said cannabis-derived compound is ed from a group consisting of one or more inoids, terpenesand any combination f; and further wherein said one or more terpenes are either at least one mono-terpene or sesqui-terpene.
3. A method for increasing at least one parameter of at least one cannabis-derived compound to a range being at least 5% over normal in a non-treated plant; terized by step of emitting a PMF on a cannab is plant or a portion thereof; said parameter is selected from a group consisting chemical parameters, n said method is provided useful for increasing the at least one first cannabis-derived compound (FCDC) to at least one second cannabis-derived compound (SCDC) ratio of a chemical parameter, said parameter is selected from a group consisting of concentration, amount, accumulation rate, % weight and % molar; said increase is to a range being at least 5% over normal such a ratio in a non-treated plant; and further wherein said method is provided useful for increasing the THC to CBD weight ratio to a range being at least 5% over normal such a ratio in a non-treated plant; characterized by step emitting a PMF on a cannabis plant or a por tion thereof. 38
4. A method for increasing at least one parameter of at least one is-derived compound to a range being at least 5% over normal in a non-treated plant; characterized by step of emitting a PMF on a cannab is plant or a portion thereof; said parameter is selected from a group consisting al parameters; wherein said method comprises steps of a. ing THC to a cannabinoid weight ratio; b. defining a desired THC to said cannabinoid weight ratio; c. exposing said cannabis plant or a portion thereof to at least one protocol of PMF emission, said protocol comprising a predefined measure of emission of PMF per time; d. analyzing resulted THC to said cannabinoid weight ratio; e. if resulted THC to said cannabinoid weight ratio equals said desired THC to said cannabinoid weight ratio, harvesting the same; f. if THC to said cannabinoid weight ratio does not equals said designated THC to a said cannabinoid weight ratio, ng said cannabis plant or a portion thereof either to said at least one first protocol or to at least one second protocol of PMF emission; said first and said second protocols comprising a predefined measure of on of PMF per time.
5. The method of claim 4, wherein said method comprises steps of a. analyzing THC to a cannabinoid weight ratio (T0 analysis); b. defining a desired THC to said cannabinoid weight ratio; c. exposing said cannabis plant or a portion f to at least one protocol of PMF emission, said protocol comprising a ined measure of emission of PMF per time; d. analyzing resulted THC to said cannabinoid weight ratio (Tn=1 analysis); e. if resulted THC to CBD weight ratio equals said desired THC to said cannabinoid weight ratio, harvesting the same; f. if THC to said cannabinoid weight ratio does not equals said designated THC to said cannabinoid weight ratio, exposing said cannabis plant or a portion thereof either to said at least one first protocol or to at least one second protocol of PMF on; said first and said second protocols comprising a ined measure of emission of PMF per time; g. analyzing ed THC to said cannabinoid weight ratio (Tn=2 analysis); 39 h. if resulted THC to CBD weight ratio equals said desired THC to said cannabinoid weight ratio, harvesting the same; i. if THC to said cannabinoid weight ratio does not equals said designated THC to said inoid weight ratio, by means of a processor, ating the function of said at least one first ol or said at least one second protocol of PMF emission on said THC to said cannabinoid weight ratio, thereby optimizing the required protocol of PMF on to provide said desired THC to said cannabinoid weight ratio; and j. exposing said cannabis plant or a n thereof to said hereto calculated optimized protocol of PMF emission.
6. The method ing to any one of claims 4 or 5, wherein said cannabinoid is selected from a group consisting of CBD, CBG, CBC and CBGA.
7. The method according to any of claims 1 to 4, wherein said chemical parameter is selected from a group consisting of amount and concentration, weight percent and molar percent of said cannabis-derived compound in the plants or portions thereof.
8. The method according to any of claims 1 to 4, wherein said method is provided useful for increasing at least one chemical parameter of both at least one first cannabis-derived compound and at least one second cannabis-derived compound to a range being at least 5% over normal in a non-treated plant; characterize d by step emitting a PMF on a cannabis plant or a portion thereof; said chemical parameter is selected from a group consisting of amount, concentration, accumulation rate (i.e., either amount per time or concentration per time), and said at least one first is-derived compound to at least one second cannabis-derived compound (wt/wt) or (mole/mole) ratio.
9. The method according to any of claims 1 to 4, wherein said method is provided useful for increasing the ratio of at least one chemical parameter of at least one first cannabisderived nd over at least one second is-derived compound to a range being at least 5% over normal such a ratio in a non-treated plant; characterized by step emitting a PMF on a is plant or a portion the reof; said chemical parameter is 269 0 Rselected from a group consisting of amount, concentration, accumulation rate (i.e.,either amount per time or concentration per time), and said ratio is selected from a group consisting of (wt/wt) and (mole/mole) ratio. 40
IL275941A 2018-03-29 2020-07-09 Physical means and methods for affecting cannabis plants IL275941B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862649598P 2018-03-29 2018-03-29
PCT/IL2019/050366 WO2019186568A1 (en) 2018-03-29 2019-03-28 Physical means and methods for affecting cannabis plants

Publications (2)

Publication Number Publication Date
IL275941A true IL275941A (en) 2020-08-31
IL275941B IL275941B (en) 2021-04-29

Family

ID=68058082

Family Applications (1)

Application Number Title Priority Date Filing Date
IL275941A IL275941B (en) 2018-03-29 2020-07-09 Physical means and methods for affecting cannabis plants

Country Status (2)

Country Link
IL (1) IL275941B (en)
WO (1) WO2019186568A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114027324B (en) * 2021-11-24 2023-05-30 中国科学院成都生物研究所 Application of liverwort in preventing and treating root rot
IL295573B2 (en) * 2022-08-11 2024-07-01 R P Grow Tec Innovations Ltd A drying room for post harvesting processes, modules and methods thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8896211B2 (en) * 2013-01-16 2014-11-25 Orteron (T.O) Ltd Physical means and methods for inducing regenerative effects on living tissues and fluids

Also Published As

Publication number Publication date
IL275941B (en) 2021-04-29
WO2019186568A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
IL275941A (en) Physical means and methods for affecting cannabis plants
WO2005072719A8 (en) Medicinal acidic cannabinoids
Schubert et al. Efficacy of cannabinoids in a pre-clinical drug-screening platform for Alzheimer’s disease
Cook et al. Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources
Wang et al. Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies
Roberts et al. Influence of pesticide regulation on acute poisoning deaths in Sri Lanka
Snyder et al. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II‐interactive properties of bioflavonoids in Chinese hamster V79 cells
Luiz et al. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms
MY171310A (en) A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
Noreen et al. Two new isoflavones from Ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis
Punna et al. A hierarchy of aryloxide deprotection by boron tribromide
BRPI0514720A (en) herbicidal combinations with special ketoenols
Hu et al. The effect of quercetin on diabetic nephropathy (DN): a systematic review and meta-analysis of animal studies
WO2009125198A3 (en) Cannabis sativa piants rich in cannabi chromene and its acid, extracts thereof and methods of obtaining extracts therefrom
GB2597170A (en) Diluents for compositions of cannabinoids and uses thereof
Das et al. Effect of green tea (camellia sinensis l.) leaf extract on reproductive system of adult male albino rats
MX2020007960A (en) Methods of purifying cannabinoids using liquid:liquid chromatography.
Kraus et al. Comparison of phenolic compounds from galls and shoots of Picea glauca
Kiani et al. Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19
Gingrich et al. Review of the oral toxicity of cannabidiol (CBD)
Fan et al. Epigallocatechin gallate induces embryonic toxicity in mouse blastocysts through apoptosis
Maia et al. Larvicidal effect from different Annonaceae species on Culex quinquefasciatus
Hidalgo et al. 4‐Phenylphenalenones as a template for new photodynamic compounds against Mycosphaerella fijiensis
CO6300909A2 (en) COMPOSITION TO CONTROL A DISEASE IN PLANTS INCLUDING PIRAZOLINONE, A SUBSTITUTED BENZENE COMPOUND AND AN AGROCHEMICALLY ACCEPTABLE SALT OF THE SAME
Kaczor et al. Commercial delta-8 THC products: an analysis of content and labeling

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed